Microvascular complications are associated with low levels of maternal sE-selectin and sVCAM-1 in pregnancy complicated with pregestational diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 88, Issue 2, 2010, Pages 164-170

  Zawiejska, Agnieszka ^a   Wender Ozegowska, Ewa ^a   Brazert, Jacek ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Diabetes; Nephropathy; Pregnancy; Retinopathy; SE selectin; SVCAM 1; Vascular sendothelium

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE MARKER; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MICROANGIOPATHY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PROTEIN BLOOD LEVEL; VASCULAR ENDOTHELIUM;

ADULT; CASE-CONTROL STUDIES; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; GESTATIONAL AGE; HUMANS; MICROVESSELS; PREGNANCY; PREGNANCY IN DIABETICS; PROSPECTIVE STUDIES; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR DISEASES; YOUNG ADULT;

EID: 77952887634     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.01.011     Document Type: Article

References (32)

1. Dunne F.P. Pregestational diabetes mellitus and pregnancy. Trends Endocrinol. Metab. 1999, 10:179-182.
2. Suhonen L., Hiilesmaa V., Teramo K. Glycemic control during early pregnancy and fetal malformations in women with type 1 diabetes mellitus. Diabetologia 2000, 43:79-82.
3. Reece E.A., Sivan E., Francis E., Homko C.J. Pregnancy outcomes among women with and without diabetic microvascular disease (White's classes B to FR) versus non-diabetic controls. Am. J. Perinatol. 1998, 15:549-555.
4. Langer O., Conway D.L. Level of glycemia and perinatal outcome in pregestational diabetes. J. Matern. Fetal Med. 2000, 9:35-41.
5. Ekbom P., Damm P., Feldt-Rasmussen B., Feldt-Rasmussen U., Mølvig J., Mathiesen E.R. Pregnancy outcome in Type 1 diabetic women with microalbuminuria. Diabetes Care 2001, 24:1739-1744.
6. Lepercq J., Taupin P., Dubois-Laforgue D., Duranteau L., Lahlou N., Boitard C., et al. Heterogeneity of growth in type 1 diabetic pregnancy. Diabetes Metab. 2001, 27:339-344.
7. Manderson J.G., Mullan B., Patterson C.C., Hadden D.R., Traub A.I., McCance D.R. Cardiovascular and metabolic abnormalities in the offspring of diabetic pregnancy. Diabetologia 2002, 45:991-996.
8. Temple R.C., Aldridge V.A., Sampson M.J., Greenwood R.H., Heyburn P.J., Glenn A. Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes. Diabet. Med. 2001, 18:573-577.
9. Wender-Ozegowska E., Zawiejska A., Pietryga M., Zozulińska D., Wierusz-Wysocka B., Chmaj K., et al. Effect of pregnancy on diabetic vascular complications. Ginekol. Pol. 2004, 75:342-351.
10. Wierusz-Wysocka B., Zozulinska D. Pathogenesis of late complications of diabetes. 1. The role of endothelial dysfunction. Diabetol. Pol. 2000, 7:193-197.
11. Wierusz-Wysocka B. Endothelial dysfunction in pathogenesis of late diabetic complications. Can it be treated?. Diabetol. Pol. 2003, 10:279-284.
12. Zozulinska D., Sobieska M., Wiktorowicz K., Wierusz-Wysocka B. Levels of serum cell adhesion molecules in type I diabetic patients with microangiopathy. Diabetologia 1999, 42:A319.
13. Zozulińska D., Wierusz-Wysocka B. The role of polymorphonuclear neutrophils in the pathogenesis of late diabetic complications. Diabet. Prakt. 2004, 5:139-142.
14. Fasching P., Veitl M., Rohac M., Streli C., Schneider B., Waldhäusl W., et al. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 1998, 81:4131-4137.
15. Koga M., Otsuki M., Kubo M., Hashimoto J., Kasayama S. Relationship between vascular cell adhesion molecule-1 and microvascular complications in type 2 diabetes mellitus. Diabet. Med. 1998, 15:661-667.
16. Roep B.O., Heidenthal E., de Vries R.R., Kolb H., Martin S. Soluble forms of intercelullar adhesion molecule-1 in insulin-dependent diabetes mellitus. Lancet 1994, 343:1590-1593.
17. Ang C., Hillier C., Cameron A.D., Greer I.A., Lumsden M.A. The effect of type 1 diabetes mellitus on vascular response to endothelin-1 in pregnant women. J. Clin. Endocrinol. Metab. 2001, 86:4939-4942.
18. Kunkel S., Briese V., Rohde E., Friese K. Investigation of adhesion molecules (sVCAM-1) in serum of nonpregnant women, normotensive pregnant women and in patients with pregnancy complications. Zentralbl. Gynakol. 1999, 121:196-197.
19. Raynor B.D., Parthasarathy S. Maternal serum vascular cell adhesion molecule concentration during pregnancy. J. Soc. Gynecol. Invest. 1997, 4:78-80.
20. Krauss T., Emons G., Kuhn W., Augustin H.G. Predicitive value of routine circulating soluble endothelial cell adhesion molecule measurements during pregnancy. Clin. Chem. 2002, 48:1418-1425.
21. Pertyńska M.P., Banasik M., Tchórzewski H., Cypryk K., Wilczyński J. Evaluation of some neutrophil adhesion molecules in pregnancy complicated by diabetes mellitus type 1. Ginekol. Pol. 2000, 71:480-490.
22. Galettis A., Campbell S., Morris J.M., Jackson C.J., Twigg S.M., Gallery E.D. Monocyte adhesion to decidual endothelial cells is increased in pregnancies complicated by Type 1 diabetes but not by gestational diabetes. Diabetes Care 2004, 27:2514-2515.
23. Diabetes Pregnancy Group, France French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 2003, 26:2990-2993.
24. Wender-Ozegowska E., Biczysko R. Vascular complications and their effect on fetal-maternal outcome and therapeutic approach in diabetic women. Ginekol. Pol. 2004, 75:385-396.
25. Taylor R., Davidson J.M. Type 1 diabetes and pregnancy. BMJ 2007, 334:742-745.
26. Grykiel K., Zozulińska D., Kostrzewa A., Wiktorowicz K., Wierusz-Wysocka B. Evaluation of expression of polymorphonuclear neutrophil surface receptors in patients with type 1 diabetes. Pol. Arch. Med. Wewn. 2001, 105:377-381.
27. Clausen P., Jacobsen P., Rossing K., Jansen J.S., Parving H.H., Feldt-Rasmussen B. Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabet. Med. 2000, 17:644-649.
28. Lim S.C., Caballero A.E., Smakowski P., LoGerfo F.W., Horton E.S., Veves S. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care 1999, 22:1865-1870.
29. Matsumoto K., Sera Y., Ueki Y., Inukai G., Niiro E., Miyake S. Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy. Diabet. Med. 2002, 19:822-826.
30. Gibson J.L., Lyall F., Boswell F., Young A., Maccuish A., Green I.A. Circulating cell adhesion molecules concentrations in diabetic women during pregnancy. Obstet. Gynecol. 1997, 90:874-879.
31. Zhou Y., Fisher S.J., Janatpour M., Gebancev O., Dejana E., Wheelock M., et al. Human cytotrophoblast adopt a vascular phenotype as they differentiate. J. Clin. Invest. 1997, 99:2139-2151.
32. Zygmunt M., Boving B., Wienhard J., Munstedt K., Braems G., Bohle R.M., et al. Expression of cell adhesion molecules in the extravillous trophoblast is altered in IUGR. Am. J. Reprod. Immunol. 1997, 38:295-301.